InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+21.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Browse the full record of transactions filed by Karim Dabbagh, Président. Insider active across 1 company, notably MAAT PHARMA. Cumulatively, 1 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €10k. Activity tracked since 22 December 2023. The latest transaction was disclosed on 22 December 2023 (Acquisition). Regulator: AMF. The full history is openly available.
Declarations1 total
1,960 shares@ €5.10100.0% of flowActionEuronext Paris2024DD946682
Ideal exit: 17 Sept 2024 (T+270)
1 of 1 declaration
About Karim Dabbagh
Karim Dabbagh is the Independent Chairman of the Board at Maat Pharma. In this role, he oversees the activities of the board and ensures the governance of the company. His experience in the pharmaceutical sector and strategic vision are essential for guiding Maat Pharma towards its objectives.
